Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
96937404 | 9693740 | 4 | F | 20160622 | 20131118 | 20160707 | EXP | IT-CELGENEUS-083-50794-13110739 | CELGENE | TERESA VOSO M, GIUSEPPE L, PICIOCCHI A, FIANCHI L, DI BARTOLOMEO P, CANDONI A. FEASIBILILTY OF AZACITIDINE AS BRIDGE TO ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH HIGHER-RISK MDS OR LOW-BLAST COUNT AML: RESULTS OF THE BMT-AZA MULTICENTER PROSPECTIVE STUDY. 2015;. | 0.00 | Y | 0.00000 | 20160707 | OT | IT | IT |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
96937404 | 9693740 | 1 | PS | VIDAZA | AZACITIDINE | 1 | Subcutaneous | U | 50794 | INJECTION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
96937404 | 9693740 | 1 | Myelodysplastic syndrome |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
96937404 | 9693740 | DE |
96937404 | 9693740 | LT |
96937404 | 9693740 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
96937404 | 9693740 | Abdominal pain | |
96937404 | 9693740 | Acute kidney injury | |
96937404 | 9693740 | Anaemia | |
96937404 | 9693740 | Anaemia of malignant disease | |
96937404 | 9693740 | Aneurysm | |
96937404 | 9693740 | Angina pectoris | |
96937404 | 9693740 | Anorectal infection | |
96937404 | 9693740 | Arthropathy | |
96937404 | 9693740 | Blood disorder | |
96937404 | 9693740 | Bronchitis | |
96937404 | 9693740 | Bronchopulmonary aspergillosis | |
96937404 | 9693740 | Bursitis | |
96937404 | 9693740 | Cardiac arrest | |
96937404 | 9693740 | Complications of transplant surgery | |
96937404 | 9693740 | Constipation | |
96937404 | 9693740 | Deafness | |
96937404 | 9693740 | Death | |
96937404 | 9693740 | Dehydration | |
96937404 | 9693740 | Diarrhoea | |
96937404 | 9693740 | Endocarditis | |
96937404 | 9693740 | Erythema | |
96937404 | 9693740 | Face oedema | |
96937404 | 9693740 | Fatigue | |
96937404 | 9693740 | Febrile neutropenia | |
96937404 | 9693740 | Gastroenteritis | |
96937404 | 9693740 | Gastrointestinal disorder | |
96937404 | 9693740 | Graft versus host disease | |
96937404 | 9693740 | Graft versus host disease in skin | |
96937404 | 9693740 | Haematuria | |
96937404 | 9693740 | Haemorrhage intracranial | |
96937404 | 9693740 | Hepatic failure | |
96937404 | 9693740 | Hepatic infection | |
96937404 | 9693740 | Herpes zoster | |
96937404 | 9693740 | Infection | |
96937404 | 9693740 | Interstitial lung disease | |
96937404 | 9693740 | Intra-abdominal haemorrhage | |
96937404 | 9693740 | Laryngeal pain | |
96937404 | 9693740 | Lower respiratory tract infection | |
96937404 | 9693740 | Lung disorder | |
96937404 | 9693740 | Lung infection | |
96937404 | 9693740 | Middle ear inflammation | |
96937404 | 9693740 | Multiple organ dysfunction syndrome | |
96937404 | 9693740 | Musculoskeletal disorder | |
96937404 | 9693740 | Myelodysplastic syndrome | |
96937404 | 9693740 | Nasopharyngitis | |
96937404 | 9693740 | Nausea | |
96937404 | 9693740 | Neoplasm | |
96937404 | 9693740 | Neutropenia | |
96937404 | 9693740 | Pharyngeal disorder | |
96937404 | 9693740 | Pharyngitis | |
96937404 | 9693740 | Pneumonia | |
96937404 | 9693740 | Pyrexia | |
96937404 | 9693740 | Respiratory failure | |
96937404 | 9693740 | Sepsis | |
96937404 | 9693740 | Septic shock | |
96937404 | 9693740 | Sialoadenitis | |
96937404 | 9693740 | Swelling | |
96937404 | 9693740 | Thrombocytopenia | |
96937404 | 9693740 | Thrombocytopenic purpura | |
96937404 | 9693740 | Toxoplasmosis | |
96937404 | 9693740 | Urinary tract infection | |
96937404 | 9693740 | Urticaria | |
96937404 | 9693740 | Weight decreased | |
96937404 | 9693740 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |